Application of kojic acid scaffold in the design of non‐tyrosinase enzyme inhibitors
Abstract Kojic acid (KA) is a hydroxypyranone natural metabolite mainly known as tyrosinase inhibitor. Currently, this compound is used as a whitening agent in cosmetics and as an anti‐browning agent in food industry. Given the easy‐manipulation in different positions of the KA molecule, many investigations have been carried out to find new tyrosinase inhibitors derived from KA. Beside anti‐tyrosinase activity, many KA‐based compounds have been designed for targeting other enzymes including human neutrophil elastase, catechol‐ O‐methyltransferase, matrix metalloproteinases, monoamine oxidase, human lactate dehydrogenase, endonucleases, D‐amino acid oxidase, and receptors such as histamine H3 and apelin (APJ) receptors. This review could help biochemists and medicinal chemists in designing diverse KA‐derived enzyme inhibitors..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
|---|---|
| Enthalten in: |
Chemical Biology & Drug Design - 100(2022), 2, Seite 290-303 |
| Beteiligte Personen: |
Ashooriha, Morteza [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
Copyright © 2022 John Wiley & Sons A/S |
|---|
| Umfang: |
14 |
|---|
| doi: |
10.1111/cbdd.14065 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY003109925 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY003109925 | ||
| 003 | DE-627 | ||
| 005 | 20230307123917.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230213s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/cbdd.14065 |2 doi | |
| 028 | 5 | 2 | |a CBDD_CBDD14065.xml |
| 035 | |a (DE-627)WLY003109925 | ||
| 035 | |a (WILEY)CBDD14065 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 540 |a 610 |q ASE |
| 084 | |a 35.76 |2 bkl | ||
| 084 | |a 35.62 |2 bkl | ||
| 084 | |a 42.13 |2 bkl | ||
| 084 | |a 58.28 |2 bkl | ||
| 100 | 1 | |a Ashooriha, Morteza |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of kojic acid scaffold in the design of non‐tyrosinase enzyme inhibitors |
| 264 | 1 | |c 2022 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Copyright © 2022 John Wiley & Sons A/S | ||
| 520 | |a Abstract Kojic acid (KA) is a hydroxypyranone natural metabolite mainly known as tyrosinase inhibitor. Currently, this compound is used as a whitening agent in cosmetics and as an anti‐browning agent in food industry. Given the easy‐manipulation in different positions of the KA molecule, many investigations have been carried out to find new tyrosinase inhibitors derived from KA. Beside anti‐tyrosinase activity, many KA‐based compounds have been designed for targeting other enzymes including human neutrophil elastase, catechol‐ O‐methyltransferase, matrix metalloproteinases, monoamine oxidase, human lactate dehydrogenase, endonucleases, D‐amino acid oxidase, and receptors such as histamine H3 and apelin (APJ) receptors. This review could help biochemists and medicinal chemists in designing diverse KA‐derived enzyme inhibitors. | ||
| 700 | 1 | |a Ahmadi, Reza |4 aut | |
| 700 | 1 | |a Ahadi, Hamideh |4 aut | |
| 700 | 1 | |a Emami, Saeed |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemical Biology & Drug Design |g 100(2022), 2, Seite 290-303 |w (DE-627)WLY003106209 |x 17470285 |7 nnns |
| 773 | 1 | 8 | |g volume:100 |g year:2022 |g number:2 |g pages:290-303 |g extent:14 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 35.76 |q ASE |
| 936 | b | k | |a 35.62 |q ASE |
| 936 | b | k | |a 42.13 |q ASE |
| 936 | b | k | |a 58.28 |q ASE |
| 951 | |a AR | ||
| 952 | |d 100 |j 2022 |e 2 |h 290-303 |g 14 | ||